
Gimv et al. back Multiplicom
Gimv, Biotechfonds Vlaanderen, VIB and the University of Antwerp have backed molecular diagnostics company Multiplicom with €2m.
The investment will be used to develop the diagnostic test, CE-marking of diagnostic assays and build a sales network in the European Union.
Company
Niel-based Multiplicom is a spin out of Jurgen Del-Favero lab of the VIB Department of Molecular Genetics at the University of Antwerp. The researcher develops, manufactures and commercialises molecular genetic tests. The firm also offers diagnostic assays for breast cancer and cystic fibrosis and has developed the MultiplexerTM technology in collaboration with pharma companies to identify genetic markers linked to drug safety and efficacy.
People
Dirk Pollet is CEO at Mulitplicom.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater